Scientific, Regulatory & Quality | Medical Writing & Submissions

IND/CTA/IMPD & NDA/BLA Enablement

Submission-ready, from your first IND to NDA/BLA.
Clear, compliant, reviewer-ready submissions, with clinical, nonclinical and CMC content authored, quality control checked and coordinated by one integrated team.
Medical writer reviewing digital content for accurate and compliant regulatory documents.

Accelerate with clear, compliant submissions.

Every IND, CTA, IMPD, NDA or BLA is a turning point for your program, and a submission is only as strong as the development work behind it. Syner-G’s medical writers turn complex data into precise, submission-ready documentation that meets global standards, avoids agency back-and-forth and helps you move forward with confidence.

Because we also bring technical and regulatory authors, quality professionals and regulatory operations specialists to the table, your submission comes together as one coherent package. Clinical, nonclinical and CMC content tell the same story, and the IND-enabling work is scoped from day one so there are no surprises when it’s time to file.

From authoring and editing to QC, formatting and coordination, we help you meet tight timelines, without compromising quality.

Written for reviewers

Every protocol, report and module is crafted with regulatory reviewers in mind: precise, consistent and credible.

One package, one team

Medical writing, Regulatory CMC, quality and regulatory operations working together, with no handoffs between functions.

Scoped from day one

Submission-enabling packages planned early, so data, documents and timelines line up when it’s time to file.

Challenges we can help solve:

0%+

Client Return Rate

0+

Assets Supported

0+

INDs Filed

0+

 NDAs / BLAs Filed

Expertise in every document.

From first IND to NDA/BLA, we support the full range of documents behind drug development and approval, each one crafted with precision. Let’s talk about your next submission.
Talk to an Expert

Regulatory support at every stage.

Every module. One team.

Strong submissions come from teams that work together. Our medical writers, technical and regulatory authors, quality professionals and regulatory operations specialists coordinate from the first outline to the final publish.

Clinical & Nonclinical Writing

Module 2 overviews and summaries plus Module 4 nonclinical and Module 5 clinical content, along with protocols, CSRs, Investigator Brochures, safety narratives and integrated summaries, written by scientists who understand the data.

CMC Module 3

Module 3 (3.2.S, 3.2.P) strategy and authoring, amendments and comparability packages from our Regulatory CMC team.

Quality Readiness

Quality input to IND/IMPD/CTA Module 3, plus PAI and BIMO inspection readiness ahead of your NDA, BLA or MAA.

Regulatory Operations

Formatting, QC, publishing and coordination that keep large submissions consistent and on schedule.

Our Approach

Specialized, scientific writing that meets global requirements.

Our medical writers integrate seamlessly into your program teams, handling everything from authoring and quality control to formatting and submission coordination, so you can meet tight timelines without compromising quality. Because they work alongside our CMC, regulatory, and quality experts, your documents are scientifically sound from the first draft.

  • Scientists: well-versed writers who craft clean, precise documents that meet global regulations
  • Quality control: data integrity assessments and consistency in style and messaging
  • Fit-for-purpose, risk-based approach: grounded in science, regulatory and operations
  • Integrated with CMC and quality: clinical, nonclinical and CMC content that tells one consistent story
  • Hands-on support: for all phases, from first-in-human studies through commercialization

We can help with:

Regulatory Submissions

IND / IMPD / CTA applications and amendments

NDAs / BLAs and MAAs

CTD Modules 2, 3, 4 and 5 authoring: summaries and overviews (Module 2), quality/CMC (Module 3, including 3.2.S and 3.2.P), nonclinical (Module 4) and clinical (Module 5)

INTERACT and Pre-IND briefing books

Briefing documents for agency and advisory committee meetings

Annual reports to regulatory agencies

Clinical & Safety Documents

Clinical study reports and protocols

Investigator Brochures

Safety narratives

Integrated summaries of safety, efficacy and immunogenicity

Complex data analyses and concise presentation of study results

Quality & Operations

QC services in medical writing

Formatting, publishing and submission coordination

Agency response coordination

Documentation gap remediation and harmonization

Let's move from science to success.

Let’s Talk